Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PB) Cash from Restructuring (2017 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Cash from Restructuring for 9 consecutive years, with $78000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Restructuring fell 47.65% year-over-year to $78000.0, compared with a TTM value of $254000.0 through Dec 2025, up 4.96%, and an annual FY2025 reading of $136000.0, down 43.8% over the prior year.
  • Cash from Restructuring was $78000.0 for Q4 2025 at Global Medical REIT, up from $16000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $154000.0 in Q3 2022 and bottomed at $11000.0 in Q3 2024.
  • Average Cash from Restructuring over 5 years is $64055.6, with a median of $46500.0 recorded in 2021.
  • The sharpest move saw Cash from Restructuring crashed 90.2% in 2023, then surged 577.27% in 2024.
  • Year by year, Cash from Restructuring stood at $45000.0 in 2021, then soared by 184.44% to $128000.0 in 2022, then crashed by 82.81% to $22000.0 in 2023, then soared by 577.27% to $149000.0 in 2024, then crashed by 47.65% to $78000.0 in 2025.
  • Business Quant data shows Cash from Restructuring for GMRE-PB at $78000.0 in Q4 2025, $16000.0 in Q3 2025, and $149000.0 in Q4 2024.